Related Experiment Video
Updated: May 11, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Current pathways for epidemiological research in amyotrophic lateral sclerosis
Pam Factor-Litvak1, Ammar Al-Chalabi, Alberto Ascherio
1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA. prf1@columbia.edu
Epidemiology of Amyotrophic Lateral Sclerosis (ALS) is complex. Future research should focus on well-characterized patient cohorts, biological samples, and gene-environment interactions to advance understanding of this neurodegenerative disease.
Area of Science:
- Neurodegenerative diseases
- Epidemiology
- Amyotrophic Lateral Sclerosis (ALS)
Background:
- Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease.
- Understanding ALS epidemiology is crucial for developing effective interventions.
- Current research faces challenges in study design and data collection.
Purpose of the Study:
- To review the current epidemiological status of ALS.
- To identify challenges and propose novel study designs for ALS research.
- To highlight key areas for future research in ALS etiology and risk factors.
Main Methods:
- Review of large-scale population-based prospective studies.
- Analysis of case-control studies and population-based registries.
- Examination of neuropathologic findings and risk factors, including environmental exposures.
Main Results:
- Discussion of time-trends in ALS incidence and prevalence.
- Identification of specific risk factors: military service, lifestyle, statin use, and BMAA exposure.
- Exploration of gene-environment interactions and syndromic aspects of ALS.
Conclusions:
- Future research requires well-characterized ALS patient cohorts and stored biological material.
- Leveraging resources like the National ALS Registry is essential.
- Multidisciplinary collaboration and investigation into early-life etiology are recommended to advance ALS epidemiology.
More Related Videos
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Parkinson's Disease: Overview
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

